Company record
Swisschems
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Swisschems.
Warning letters
-
DrugsSwisschems
Swisschems sells Semaglutide and Retatrutide as unapproved new drugs despite research-chemical labeling.
High risk